The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> March 8, 2018

Interview with the CEO: Race Oncology Ltd. (ASX:RAC)

Molloy, Peter
Peter Molloy is Chief Executive Officer of Race Oncology Ltd. Peter Molloy graduated from the University of Melbourne as a microbiologist and biochemist, and then worked for 18 years in the pharmaceutical industry. At the Australian pharmaceutical company Faulding, he managed several Faulding subsidiaries before joining Pharmacia — now Pfizer — as Managing Director of its Australia and NZ operations, where he managed four pharmaceutical marketing divisions including the oncology business. Promoted to Vice President of Strategic Marketing, he was then responsible for Pharmacia’s marketing strategy and portfolio across 22 countries throughout Asia Pacific and Latin America. Subsequently, he served as CEO of three biotechnology companies — Biota Holdings Ltd., SLIL Biomedical Corp. and Florigene Ltd. — where he managed numerous R&D programs, raised substantial equity funding and executed four pharmaceutical partnerships. During his tenure as CEO of the ASX-listed company Biota Holdings Ltd., the company’s market value grew from approximately $30 million to nearly $300 million in three and a half years. During his career, he has managed eight biotechnology or pharmaceutical businesses, launched 23 pharmaceutical products and executed 40 international licensing or distribution deals. He holds a B.S. from the University of Melbourne and an MBA from the University of Adelaide. He is also a fellow of the Australian Institute of Company Directors and has served on several Australian and U.S. boards. Profile
TWST: Can you describe Race Oncology and what makes it different?

Mr. Molloy: Race Oncology is a specialty pharmaceutical company rather than a biotech company.

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
Interview with the Founder and Executive Chairman: Organovo Holdings Inc. (NASDAQ:ONVO)
Interview with the Co-Founder and CEO: Equillium Inc. (NASDAQ:EQ)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Electric Cars and AI Fuel Long-Term Electricity Demand
Separating the Real Winners and Losers in the AI Boom
Generating Dividend Yield That’s Not Correlated to Interest Rates
ANALYST INTERVIEWS
Robust M&A Activity Provides Tailwind to Biotech Sector
Seeking Out Game Changers in Re-Emerging Biotech Sector
Obesity Drugmakers Still a ‘Buy’ Despite Lofty Valuations
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy